Wegovy, a higher-dose range formulation of semaglutide, was approved for weight management in 2023
requires medical knowledge to minimize risk Intranasal Intranasal delivery to target the olfactory bulb and trans-cribriform access to the brain has been explored for some peptides: Theoretical advantage: Direct CNS access, bypassing the blood-brain barrier Reality: Intranasal peptide formulations are complex and Dihexa is not commonly available in this form Evidence: No published data on intranasal Dihexa efficacy or safety Oral Bioavailability: Approximately 38% The most commonly cited bioavailability figure for oral Dihexa is approximately 38%
doi: 10.1186/s13073-017-0407-3 42 DuffyDJKrsticAHalaszMSchwarzlTFeyDIljinKet al
The proportions participating in only 3, 2, 1 and no group sessions, respectively, were 3.7%, 1.9%, 0.9% and 13.6%, respectively
"Once I'd been on the drug for a while, my sex drive did come back, but I wouldn't say it's super strong," she said